Kishino H, Inoue S, Matsuoka O, Yagi M, et al. A phase 3 randomized trial (STRIDE-9) to evaluate the safety, tolerability, and immunogenicity of V116, a population-specific pneumococcal conjugate vaccine, in pneumococcal vaccine-naive Japanese adults >/=65 years of age. Vaccine 2025;62:127456.
PMID: 40763490